Literature DB >> 9685496

Targeting of CDK8 to a promoter-proximal RNA element demonstrates catalysis-dependent activation of gene expression.

M O Gold1, A P Rice.   

Abstract

During transcription of mRNA genes, there is a correlation between the phosphorylation state of the C-terminal domain (CTD) of the large subunit of RNA polymerase II (RNAP II) and the ability of the RNAP II complex to processively transcribe the gene. To examine the involvement of CTD phosphorylation in modulation of RNAP II function, we have analyzed the ability of a known CTD kinase, human Cdk8, to modulate HIV-1 LTR-driven gene expression upon directed targeting to a promoter-proximal nascent RNA element. The results indicated that Cdk8, when localized to an RNA element, activates gene expression in a catalysis-dependent manner. Also, Cdk8 targeted to RNA was observed to act in a synergystic manner with DNA-targeted Sp1 but not with DNA-targeted HIV-1 Tat, suggesting that RNA-targeted Cdk8 acts on similar rate limiting post-initiation events as Tat. As recent observations suggest that Tat/TAR-mediated transcription of the proviral genome of HIV depends on specific phosphorylation of RNAP II in its CTD by the Tat-associated kinase (TAK/p-TEFb/Cdk9), our results indicate that Cdk8 shares with Cdk9 the ability to modulate transcription upon targeting to a nascent RNA element.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9685496      PMCID: PMC147767          DOI: 10.1093/nar/26.16.3784

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  36 in total

1.  The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.

Authors:  L S Tiley; S J Madore; M H Malim; B R Cullen
Journal:  Genes Dev       Date:  1992-11       Impact factor: 11.361

2.  PITALRE, the catalytic subunit of TAK, is required for human immunodeficiency virus Tat transactivation in vivo.

Authors:  M O Gold; X Yang; C H Herrmann; A P Rice
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product.

Authors:  S Y Kao; A F Calman; P A Luciw; B M Peterlin
Journal:  Nature       Date:  1987 Dec 3-9       Impact factor: 49.962

4.  Transcription factors IIE and IIH and ATP hydrolysis direct promoter clearance by RNA polymerase II.

Authors:  J A Goodrich; R Tjian
Journal:  Cell       Date:  1994-04-08       Impact factor: 41.582

5.  Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation.

Authors:  T O'Brien; S Hardin; A Greenleaf; J T Lis
Journal:  Nature       Date:  1994-07-07       Impact factor: 49.962

6.  Exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA.

Authors:  H Rhim; A P Rice
Journal:  Nucleic Acids Res       Date:  1994-10-25       Impact factor: 16.971

7.  Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif.

Authors:  T J Hope; X J Huang; D McDonald; T G Parslow
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

8.  The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function.

Authors:  C D Southgate; M R Green
Journal:  Genes Dev       Date:  1991-12       Impact factor: 11.361

9.  Conservation of the mammalian RNA polymerase II largest-subunit C-terminal domain.

Authors:  E Barron-Casella; J L Corden
Journal:  J Mol Evol       Date:  1992-11       Impact factor: 2.395

10.  Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.

Authors:  J Kamine; T Subramanian; G Chinnadurai
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

View more
  17 in total

Review 1.  P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II.

Authors:  D H Price
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

Review 2.  CDK8: a positive regulator of transcription.

Authors:  Matthew D Galbraith; Aaron J Donner; Joaquín M Espinosa
Journal:  Transcription       Date:  2010 Jul-Aug

3.  Retroviral cyclin enhances cyclin-dependent kinase-8 activity.

Authors:  Joel Rovnak; Connie D Brewster; Sandra L Quackenbush
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

4.  Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.

Authors:  P D Bieniasz; T A Grdina; H P Bogerd; B R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

5.  Retroviral cyclin controls cyclin-dependent kinase 8-mediated transcription elongation and reinitiation.

Authors:  Claire H Birkenheuer; Connie D Brewster; Sandra L Quackenbush; Joel Rovnak
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

6.  HIV Transcription Is Independent of Mediator Kinases.

Authors:  Daniele C Cary; Mona Rheinberger; Ajda Rojc; B Matija Peterlin
Journal:  AIDS Res Hum Retroviruses       Date:  2019-05-29       Impact factor: 2.205

7.  The Mediator Kinase Module Restrains Epidermal Growth Factor Receptor Signaling and Represses Vulval Cell Fate Specification in Caenorhabditis elegans.

Authors:  Jennifer M Grants; Lisa T L Ying; Akinori Yoda; Charlotte C You; Hideyuki Okano; Hitoshi Sawa; Stefan Taubert
Journal:  Genetics       Date:  2015-12-29       Impact factor: 4.562

8.  MLL-ENL inhibits polycomb repressive complex 1 to achieve efficient transformation of hematopoietic cells.

Authors:  Emanuel Maethner; Maria-Paz Garcia-Cuellar; Constanze Breitinger; Sylvia Takacova; Vladimir Divoky; Jay L Hess; Robert K Slany
Journal:  Cell Rep       Date:  2013-04-25       Impact factor: 9.423

9.  CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity.

Authors:  Ron Firestein; Adam J Bass; So Young Kim; Ian F Dunn; Serena J Silver; Isil Guney; Ellen Freed; Azra H Ligon; Natalie Vena; Shuji Ogino; Milan G Chheda; Pablo Tamayo; Stephen Finn; Yashaswi Shrestha; Jesse S Boehm; Supriya Jain; Emeric Bojarski; Craig Mermel; Jordi Barretina; Jennifer A Chan; Jose Baselga; Josep Tabernero; David E Root; Charles S Fuchs; Massimo Loda; Ramesh A Shivdasani; Matthew Meyerson; William C Hahn
Journal:  Nature       Date:  2008-09-14       Impact factor: 49.962

10.  Misguided transcriptional elongation causes mixed lineage leukemia.

Authors:  Dorothee Mueller; María-Paz García-Cuéllar; Christian Bach; Sebastian Buhl; Emanuel Maethner; Robert K Slany
Journal:  PLoS Biol       Date:  2009-11-24       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.